共 50 条
- [3] Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint? JOURNAL OF CANCER POLICY, 2023, 35
- [9] Middle lobe tumors and lymphovascular invasion as independent predictors of recurrence-free survival in stage I NSCLC BMC PULMONARY MEDICINE, 2025, 25 (01):